thoracic aorta pathology
Conditions
Interventions
Present practise is that the patients undergo CTA of the aorta pre-operatively and post-operatively before discharge or after 6 to 8 weeks, after 3 to 6 months, after 12 months, and yearly thereafter.
Sponsors
University of Twente
Eligibility
Inclusion criteria
Inclusion criteria: • Asymptomatic thoracic aortic pathology • Age > 65 years • Indication for aortic pathology treatment according to standard practise • Anatomically suitability for one of the investigated grafts
Exclusion criteria
Exclusion criteria: • No informed consent obtained • eGFR < 30 ml/min • Allergy for intra venous contrast fluid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To gain insight in the parameters that influence the success and failure of the proximal fixation and/or sealing of Thoraflex Hybrid device and Relay(Branch) stent grafts. More practically, this leads to the questions of how the diameter of the (proximal) stent rings changes during the cardiac cycle (pulsatility), how the diameter changes over a period of several months (expansion) and how the grafts interact with the dynamics of the stented target vessels. | — |
Secondary
| Measure | Time frame |
|---|---|
| • How does the estimated vessel compliance change during follow-up? • Can we observe other kinds of motion that change over time? • What are the differences and similarities of thoracic endograft vs. thoracic hybrid graft (Relay(Branch) vs. Thoraflex Hybrid) considering: o Expansion? o Pulsatility? o Conformability to the native vessel? | — |
Contacts
Public ContactJaimy Simmering
University of Twente
Outcome results
None listed